Methods Ten diabetic feet were included to receive subcutaneous injection of SVF cells
around wounds. Transcutaneous partial oxygen pressure (TcPO 2) and cutaneous …

Diabetes affects multiple systems in complex manners. Diabetic foot ulcers (DFUs) are a
result of diabetes-induced microarterial vessel disease and peripheral neuropathy. The …

We previously reported 18-month results post-injection of adipose-derived stromal vascular
fraction (SVF) cells in 10 patients with end-stage peripheral vascular disease (PVD) in …

Background Cell-based therapy is being explored as an alternative treatment option for
critical limb ischemia (CLI), a disease associated with high amputation and mortality rates …

We present a series of ten patients with non-reconstructable peripheral vascular disease
(PVD), secondary to arteriosclerosis (AS) and/or diabetes mellitus (DM), treated with local …

This review provides an outline of the use of adipose-derived mesenchymal stem cells
(AMSCs) in the treatment of diabetic foot ulcers (DFUs). A systematic search of PubMed and …

Background Impaired wound healing is a major cause of morbidity in diabetic patients by
causing chronic ulcers. This study aimed to investigate the safety and outcomes after …

Background: Treatment of critical limb ischemia (CLI) by bypass operation or percutaneous
vascular intervention is occasionally difficult. The safety and efficacy of multiple …

Diabetes mellitus contributes to 15–25% of all chronic foot ulcers. Peripheral vascular
disease is a cause of ischemic ulcers and exacerbates diabetic foot disease. Cell-based …

Aim The aim of our study was to assess safety and effectiveness of therapy of critical limb
ischaemia by autologous stem cells and evaluation of potential adverse events. Methods …